<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02222779</url>
  </required_header>
  <id_info>
    <org_study_id>KPUK-14-Metal</org_study_id>
    <nct_id>NCT02222779</nct_id>
  </id_info>
  <brief_title>Quantification of Transition Metals</brief_title>
  <official_title>Quantification of Transition Metals in Patients at the Cologne University Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <brief_summary>
    <textblock>
      In this trial, concentrations of transition metals of interest are quantified in surplus
      cerebrospinal fluid (CSF) and blood serum samples. Quantification of the transition metals
      will be performed by inductively coupled plasma mass spectrometry (ICP-MS). The treating
      physicians as well as the patients will not be informed about the results of drug
      concentrations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Samples used include:

      Remaining portions of samples collected for diagnostic or therapeutic reasons (paired CSF and
      blood serum samples). No lumbar puncture will be done specifically for this protocol.

      The objective of this study is to gain an overview about transition metals concentrations in
      blood serum and CSF in order to provide preliminary data on patients. The effect of
      neurodegenerative diseases on metals or the other way round will be assessed if possible.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2014</start_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Transition metal concentration</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Neurodegenerative Diseases</condition>
  <condition>Infections</condition>
  <arm_group>
    <arm_group_label>Patients with Parkinson´s Disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient´s with Alzheimer´s Disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with Multiple Sclerosis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with any other neurodegenerative diseases</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Remaining portions of samples collected for diagnostic or therapeutic reasons (paired CSF and
      blood serum samples). No lumbar puncture will be done specifically for this protocol.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        neurodegenerative diseases infections
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: •

          -  The trial will include any patient (with various diseases, especially
             neurodegenerative diseases) who received a lumbar puncture.

        Exclusion Criteria:

          -  • The lower age limit is 18 years. In concordance with the objective of the project
             there is no specific exclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Uwe Fuhr, Professor</last_name>
    <phone>0049221478</phone>
    <phone_ext>5230</phone_ext>
    <email>uwe.fuhr@uk-koeln.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Pharmacology</name>
      <address>
        <city>Cologne</city>
        <state>Northrhine Westphalia</state>
        <zip>50829</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Uwe Fuhr, Professor</last_name>
      <phone>0049221478</phone>
      <phone_ext>5230</phone_ext>
      <email>uwe.fuhr@uk-koeln.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2014</study_first_submitted>
  <study_first_submitted_qc>August 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2014</study_first_posted>
  <last_update_submitted>August 20, 2014</last_update_submitted>
  <last_update_submitted_qc>August 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Ali Mohammad Nejad Sigaroudi</investigator_full_name>
    <investigator_title>Quantification of Transition Metals in Patients at the Cologne University Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurodegenerative Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

